Cargando…

Controlling Immune Rejection Is a Fail-Safe System against Potential Tumorigenicity after Human iPSC-Derived Neural Stem Cell Transplantation

Our previous work reported functional recovery after transplantation of mouse and human induced pluripotent stem cell-derived neural stem/progenitor cells (hiPSC-NS/PCs) into rodent models of spinal cord injury (SCI). Although hiPSC-NS/PCs proved useful for the treatment of SCI, the tumorigenicity o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itakura, Go, Kobayashi, Yoshiomi, Nishimura, Soraya, Iwai, Hiroki, Takano, Morito, Iwanami, Akio, Toyama, Yoshiaki, Okano, Hideyuki, Nakamura, Masaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338009/ https://www.ncbi.nlm.nih.gov/pubmed/25706286 http://dx.doi.org/10.1371/journal.pone.0116413

Ejemplares similares

Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity
por: Kobayashi, Yoshiomi, et al.
Publicado: (2012)

Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives
por: Itakura, Go, et al.
Publicado: (2017)

Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury
por: Kawabata, Soya, et al.
Publicado: (2015)

Long-Term Safety Issues of iPSC-Based Cell Therapy in a Spinal Cord Injury Model: Oncogenic Transformation with Epithelial-Mesenchymal Transition
por: Nori, Satoshi, et al.
Publicado: (2015)

Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury
por: Nishimura, Soraya, et al.
Publicado: (2013)

Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury
por: Okubo, Toshiki, et al.
Publicado: (2016)

Functional Recovery from Neural Stem/Progenitor Cell Transplantation Combined with Treadmill Training in Mice with Chronic Spinal Cord Injury
por: Tashiro, Syoichi, et al.
Publicado: (2016)

Regenerative therapy for spinal cord injury using iPSC technology
por: Nagoshi, Narihito, et al.
Publicado: (2020)

MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates
por: Aron Badin, Romina, et al.
Publicado: (2019)

Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products
por: Kawamata, Shin, et al.
Publicado: (2015)

Inflammatory cascades mediate synapse elimination in spinal cord compression
por: Takano, Morito, et al.
Publicado: (2014)

Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases
por: Sugai, Keiko, et al.
Publicado: (2016)

Low-Intensity Pulsed Ultrasound Promotes Osteogenic Potential of iPSC-Derived MSCs but Fails to Simplify the iPSC-EB-MSC Differentiation Process
por: Hua, Ziyi, et al.
Publicado: (2022)

Enhanced Functional Recovery from Spinal Cord Injury in Aged Mice after Stem Cell Transplantation through HGF Induction
por: Takano, Morito, et al.
Publicado: (2017)

Focal Transplantation of Human iPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice
por: Kondo, Takayuki, et al.
Publicado: (2014)

Tumorigenicity Studies of Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) for the Treatment of Age-Related Macular Degeneration
por: Kanemura, Hoshimi, et al.
Publicado: (2014)

Treatment with a Gamma-Secretase Inhibitor Promotes Functional Recovery in Human iPSC- Derived Transplants for Chronic Spinal Cord Injury
por: Okubo, Toshiki, et al.
Publicado: (2018)

Cell therapy for spinal cord injury by using human iPSC-derived region-specific neural progenitor cells
por: Kajikawa, Keita, et al.
Publicado: (2020)

iPSC-Derived Regulatory Dendritic Cells Inhibit Allograft Rejection by Generating Alloantigen-Specific Regulatory T Cells
por: Cai, Songjie, et al.
Publicado: (2017)

Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
por: Isoda, Miho, et al.
Publicado: (2023)

MRI Characterization of Paranodal Junction Failure and Related Spinal Cord Changes in Mice
por: Takano, Morito, et al.
Publicado: (2012)

Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
por: Yokota, Mutsumi, et al.
Publicado: (2021)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018)

iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)

Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)

iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020)

Rehabilitative Training Enhances Therapeutic Effect of Human iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury
por: Shibata, Takahiro, et al.
Publicado: (2023)

LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury
por: Ito, Shuhei, et al.
Publicado: (2021)

Expression of ACE2 and a viral virulence-regulating factor CCN family member 1 in human iPSC-derived neural cells: implications for COVID-19-related CNS disorders
por: Kase, Yoshitaka, et al.
Publicado: (2020)

Pro-maturational Effects of Human iPSC-Derived Cortical Astrocytes upon iPSC-Derived Cortical Neurons
por: Hedegaard, Anne, et al.
Publicado: (2020)

Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury
por: Kitagawa, Takahiro, et al.
Publicado: (2022)

Comparison of two protocols for the generation of iPSC-derived human astrocytes
por: Mulica, Patrycja, et al.
Publicado: (2023)

iPSC-based model of viral infection
Publicado: (2012)

Chromatin looping is needed for iPSC induction
por: Hu, Ji-Fan, et al.
Publicado: (2014)

iPSC-MSCs and islet allograft tolerance
por: Wang, Tong-Song, et al.
Publicado: (2015)

Human iPSC banking: barriers and opportunities
por: Huang, Ching-Ying, et al.
Publicado: (2019)

Application of iPSC to Modelling of Respiratory Diseases
por: Calvert, Ben A., et al.
Publicado: (2020)

The Utilisation of Hydrogels for iPSC-Cardiomyocyte Research
por: Patel, Leena, et al.
Publicado: (2023)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6tsukqcivh42st61k8gk6u7bqa